Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Danio rerio

ABSTRACT: Whole Retina RNAseq after injury and Valproic acid (VPA) treatment in zebrafish

PROVIDER: PRJNA383995 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5469313_1.fastq.gz	Fastqsanger.gz
	SRR5469313_2.fastq.gz	Fastqsanger.gz
	SRR5469314_1.fastq.gz	Fastqsanger.gz
	SRR5469314_2.fastq.gz	Fastqsanger.gz
	SRR5469315_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Danio rerio

Project description:Whole Retina RNAseq after injury and Cyclopamine(C) treatment in zebrafish

| PRJNA396510 | ENA

Identification differentially expressed genes upon valproic acid treatment

2011-07-13 | GSE30517 | GEO

Danio rerio

Project description:Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish

| PRJNA208795 | ENA

Danio rerio

Project description:Id2a knockdown in zebrafish retina

| PRJNA168635 | ENA

Project description:tMCAO+ Valproic acid (VPA)

| PRJNA694497 | ENA

Identification differentially expressed genes upon valproic acid treatment

Project description:The goal of this study is to define genes that are differentially expressed in Down syndrome leukemic blasts after treatment with valproic acid (VPA) Here we report the identification gene sets that are downregulated in Down syndrome leukemic cell lines after exposure to valproic acid (VPA) CMK and CMY cells were treated with VPA for 24h and 48h with 1mM or 2mM VPA. Their gene expression profile was compared against the untreated control.

2011-07-12 | E-GEOD-30517 | biostudies-arrayexpress

SmartSeq2 analysis of chemically-defined MiPs with and without valproic acid treatment

Project description:We have optimized a protocol to generate chemically defined induced pluripotent stem cell-derived mesodermal progenitors. We demonstrate that these cells contribute to myotube formation that can be improved by the addition of valproic acid. Thanks to SmartSeq2 single cell RNAseq, we show that valproic acid treatment increase the number of myogenic progenitors. We also used gene set enrichment analysis to annotate the clusters further with correlations to the ARCHS4 Tissues database. In particular, we found that the gene expression profile of the VPA-treated single cell cluster correlated more to myoblasts compared to the untreated cells. Some key myogenic genes found to be differentially expressed were DESMIN and CD82, which were upregulated upon VPA supplementation.

2021-06-12 | GSE177048 | GEO

human placenta-derived cell line (JEG-3): Control vs. valproic acid(VPA)-treated

Project description:Transcriptional profiling of human placenta-derived JEG-3 cell line comparing vehicle control with 7.38 mM of valproic acid(VPA)-treated JEG-3 cells for 48 hr. 7.38 mM valproic acid(VPA) induced the 30% inhibiotion of JEG-3 cell proliferation, G1 phase cell cycle arrest and the reduction of cell size. The Goal was to analyze the mechanism of valproic acid-induced adverse effects in placental cells. Two-condition experiment, JEG-3 cells vs. valproic acid(VPA)-treated JEG-3 cells. Biological replicates: 3 control replicates, 3 VPA-treated replicates.

2012-10-11 | E-GEOD-41441 | biostudies-arrayexpress

Effect of Valproic Acid on Endothelial Cells

Project description:Valproic acid (VPA) is a short-chain fatty acid used in the treatment of epilepsy and also considered to be an epigenetic modifier by functioning as a histone deacetylase (HDAC)-inhibitor. The aim of this study was to search for gene altered by VPA in human endothelial cells.

2012-03-14 | GSE23909 | GEO

Danio rerio

Project description:Transcripts within Rod Photoreceptors of the Zebrafish Retina

| PRJNA390613 | ENA